LCM
ROIV icon

Legato Capital Management’s Roivant Sciences ROIV Stock Holding History

Legato Capital Management’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.63M Buy
45,988
+1,132
+3% +$33.5K 0.13% 228
2026
Q1 		$1.24M Sell
44,856
-484
-1% -$12.4K 0.11% 239
2025
Q4 		$984K Buy
45,340
+13,135
+41% +$259K 0.08% 364
2025
Q3 		$487K Buy
+32,205
New +$399K 0.05% 443
2024
Q1 		– Sell
-18,000
Closed -$202K – 607
2023
Q4 		$202K Sell
18,000
-46,763
-72% -$456K 0.03% 529
2023
Q3 		$756K Buy
64,763
+4,403
+7% +$49.8K 0.11% 301
2023
Q2 		$608K Buy
+60,360
New +$540K 0.08% 376

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Legato Capital Management's ROIV Position: Q2 2026 in Review

Legato Capital Management increased its Roivant Sciences (ROIV) stake by 2.5% in Q2 2026, buying an estimated $33.5K and bringing the position to 45,988 shares worth $1.63M. The position accounts for 0.13% of the portfolio, ranked #228.

Legato Capital Management first reported a position in ROIV in Q2 2023 and has held it in 7 quarters since. 499 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Legato Capital Management held 45,988 shares of Roivant Sciences worth $1.63M as of Q2 2026.
  • Legato Capital Management bought 1,132 Roivant Sciences shares in Q2 2026, an estimated $33.5K.
  • Roivant Sciences made up 0.13% of Legato Capital Management's portfolio in Q2 2026, its #228 holding.
  • Legato Capital Management first reported a position in Roivant Sciences in Q2 2023 and has held it in 7 quarters since.
  • 499 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Legato Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.